| 21-06-25 | NattoPharma ASA : - Delisting | AQ |
| 21-06-15 | NattoPharma : Received application for delisting | AQ |
| 21-06-14 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 21-06-10 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 21-06-09 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 2018-02-07 |
Robert Schrama
DFI | Director of Finance/CFO | - | 2020-03-08 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 2004-11-03 |
| Director/Board Member | 52 | 2011-01-31 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.35% | +1.46% | - | - | 86.2M | ||
| +0.11% | +2.76% | +63.52% | +115.51% | 1,055B | ||
| +0.27% | +0.73% | +51.33% | +73.10% | 654B | ||
| +0.73% | +0.88% | +20.70% | +73.89% | 467B | ||
| -1.36% | -0.39% | +40.20% | +41.03% | 348B | ||
| +1.34% | +5.47% | +23.37% | +31.30% | 275B | ||
| -0.48% | -0.06% | +13.56% | +12.36% | 258B | ||
| +0.85% | +8.42% | +53.17% | +55.45% | 224B | ||
| +0.85% | +1.40% | +35.78% | +101.47% | 187B | ||
| -0.30% | -10.41% | -27.62% | -61.04% | 171B | ||
| Average | +0.36% | +0.74% | +30.45% | +49.23% | 404.26B | |
| Weighted average by Cap. | +0.12% | +1.32% | +40.69% | +69.05% |
Employees
18
Sector
Pharmaceuticals
















